Anika Therapeutics, Inc.
Ticker: 898437
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 32.61+10.1% | 29.61+6.4% | 27.82-1.4% | 28.22+7.8% | 26.17-32.5% | 38.75-7.6% | 41.92+3.5% | 40.52 |
| Total Income | 32.61+10.1% | 29.61+6.4% | 27.82-1.4% | 28.22+7.8% | 26.17-32.5% | 38.75-7.6% | 41.92+3.5% | 40.52 |
| EXPENSES | ||||||||
| Expenditure | 18.29-25.3% | 24.49+30.1% | 18.82+1.5% | 18.54-2.3% | 18.97-35.6% | 29.46+8.3% | 27.20-8.4% | 29.69 |
| Tax | 0.07-70.8% | 0.24-74.5% | 0.94+38.2% | 0.68+655.6% | 0.09-96.1% | 2.31+175.0% | 0.84+2000.0% | 0.04 |
| PROFIT | ||||||||
| PBT | 3.38+170.1% | -4.82-115.2% | -2.24+43.6% | -3.97-2.6% | -3.87+86.0% | -27.61-3732.9% | 0.76+117.0% | -4.47 |
| Net Profit | 3.31+165.4% | -5.06-117.2% | -2.33+41.3% | -3.97+18.5% | -4.87+83.7% | -29.92-33144.4% | -0.09+98.0% | -4.51 |
| KEY METRICS | ||||||||
| OPM % | 9.06%+27.59pp | -18.53%-6.91pp | -11.62%+3.19pp | -14.81%+1.56pp | -16.37%+55.93pp | -72.30%-72.68pp | 0.38%+12.88pp | -12.49% |
| NPM % | 10.15%+27.22pp | -17.07%-8.70pp | -8.37%+5.70pp | -14.07%+4.55pp | -18.62%+58.58pp | -77.20%-76.99pp | -0.21%+10.93pp | -11.14% |
| EPS | 0.25+167.6% | -0.37-131.3% | -0.16+42.9% | -0.28+17.6% | -0.34+83.3% | -2.03-20200.0% | -0.01+96.8% | -0.31 |
Corporate Events
No corporate events found.